Structure of the neuromuscular junction: Function and cooperative mechanisms in the synapse

Annals of the New York Academy of Sciences

Volumn 1274, Issue 1, 2012, Pages 14-23

  Takamori, Masaharu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acetylcholine receptor; Calcium channel; Muscle specific tyrosine kinase (MuSK); Neuromuscular junction; Transient receptor potential canonical (TRPC); Wnt

Indexed keywords

AGRIN; CALCIUM ION; CHOLINERGIC RECEPTOR; DISHEVELLED PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN TYROSINE KINASE; RYANODINE RECEPTOR 1; WNT PROTEIN;

ACETYLCHOLINE RELEASE; ARTICLE; CALCIUM TRANSPORT; CELL VACUOLE; DEPOLARIZATION; EATON LAMBERT SYNDROME; ENDOCYTOSIS; EXOCYTOSIS; HUMAN; MUSCLE CONTRACTION; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRESYNAPTIC NERVE; SARCOPLASMIC RETICULUM; SYNAPSE; THYMOMA;

EID: 84871287620     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06784.x     Document Type: Article

References (100)

1. 2+-triggered exocytosis. Curr. Opin. Cell Biol. 22: 496-505.
2. Smith, S.M., R. Renden & H. von Gersdoff. 2008. Synaptic vesile endocytosis: fast and slow modes of membrane retrieval. Trends Neurosci. 31: 559-568.
3. 2+-dependent regulation of synaptic vesicle endocytosis. Neurosci. Res. 73: 1-7.
4. 2+-dependent formation of a dynamin-synaptophysin complex. Potential role in synaptic vesicle endocytosis. J. Biol. Chem. 277: 9010-9015.
5. Deák, F. et al. 2004. Synaptobrevin is essential for fast synaptic-vesicle endocytosis. Nat. Cell Biol. 6: 1102-1108.
6. Xue, L. et al. 2012. A membrane pool retrieved via endocytosis overshoot at nerve terminals: a study of its retrieval mechanism and role. J. Neurosci 32: 3398-3404.
7. Zhang, Q., Y. Li & R.W. Tsien. 2009. The dynamic control of kiss-and-run and vesicular reuse probed with single nanoparticles. Science 323: 1488-1453.
8. Meunier, F.A. et al. 2010. Sustained synaptic vesicle recycling by bulk endocytosis contributes to the maintenance of high-rate neurotransmitter release stimulated by glycerotoxin. J. Cell Sci. 123: 1131-1140.
9. Santafé, M.M. et al. 2006. Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal. Eur. J. Neurosci. 23: 2048-2056.
10. 2+ influx are both required for BDNF to rapidly increase quantal vesicular transmitter release. Neural Plast. 2012: 203536.
11. Lemonnier, L., M. Trebak & J.W. Putney, Jr. 2008. Complex regulation of the TRPC3, 6 and 7 channel subfamily by diacylglycerol and phosphatidylinositol- 4, 5-bisphosphate. Cell Calcium 43: 506-514.
12. Yuan, J.P. et al. 2012. The closing and opening of TRPC channels by Homer1 and STIM1. Acta Physiol. (Oxf.) 204: 238-247.
13. Bauer, C.S. et al. 2007. Potentiation of exocytosis by phospholipase C-coupled G- protein-coupled receptors requires the priming Munc13-1. J. Neurosci. 27: 212-219.
14. Oliveria, L., M.A. Timóteo & P. Correia-de-Sá. 2009. Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate. Neurosci. Lett. 459: 127-131.
15. Garcia, N. et al. 2010. The interaction between topomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals. J. Neurosci. 30: 16514-16522.
16. Minic, J. et al. 2002. Regulation of acetylcholine release by muscarinic receptor at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur. J. Neursci. 148: 432-440.
17. Santafé, M.M. et al. 2007. Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal. Neuroscience 148: 432-440.
18. Garcia, N. et al. 2005. Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat. Histol Histopathol. 20: 733-743.
19. Hulme, E.C., N.J.M. Birdsall & N.J. Buckley. 1990. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30: 633-673.
20. Kim, J.Y. & D. Saffen. 2005. Activation of M1 muscarinic acetylcholine receptors stimulates the formation of a multi-protein complex centered on TRPC6 channels. J. Biol. Chem. 280: 32035-32047.
21. Takamori, M. et al. 2007. Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Eur. J. Neurol. 14: 1230-1235.
22. Takamori, M. 2008. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. J. Neuroimmunol. 200-201: 145-152.
23. Lang, B. et al. 2003. Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann. N.Y. Acad. Sci. 998: 187-195.
24. Nishimune, H. 2012. Molecular mechanism of active zone organization at vertebrate neuromuscular junctions. Mol. Neurobiol. 45: 1-16.
25. Carlson, S.S., G. Valdez & J.R. Sanes. 2010. Presynaptic calcium channels and α3-integrins are complexed with synaptic cleft laminins, cytoskeletal elements and active zone components. J. Neurochem. 115: 654-666.
26. Kaeser, P.S. et al. 2012. RIM genes differentially contribute to organizing presynaptic release sites. Proc. Natl. Acad. Sci. USA 109: 11830-11835.
27. Wu, H., W.C. Xiong & L. Mei. 2010. To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137: 1017-1033.
28. Linnoila, J. et al. 2008. A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates agrin signaling at the neuromuscular junction. Neuron 60: 625-641.
29. Luo, S. et al. 2008. Hsp90 beta regulates rapsyn turnover and subsequent AChR cluster formation and maintenance. Neuron 60: 97-110.
30. Lee, Y., J. Rudell & M. Ferns. 2009. Rapsyn interacts with the muscle acetylcholine receptor via alpha-helical domains in the alpha, beta, and epsilon subunit intracellular loops. Neuroscience 163: 222-232.
31. Yamanashi Y., T. Tezuka & K. Yokoyama. 2012. Activation of receptor protein- tyrosine kinases from the cytoplasmic component. J. Biochem. 151: 353-359.
32. Hallock, P.T. et al. 2010. Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L. Genes Dev. 24: 2451-2461.
33. Weatherbee, S.D., K.V. Anderson & L.A. Niswander. 2006. LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133: 4993-5000.
34. Zhang, B. et al. 2008. Lrp4 serves as a coreceptor of agrin. Neuron 60: 285-297.
35. Kim, N. et al. 2008. Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135: 334-342.
36. McConville, J. et al. 2004. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann. Neurol. 55: 580-584.
37. Higuchi, O. et al. 2011. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann. Neurol. 69: 418-422.
38. Pevzner, A. et al. 2011. Anti-Lrp4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J. Neurol. 259: 427-435.
39. Zhang, B. et al. 2012. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch. Neurol. 69: 445-451.
40. Koles, K. & V. Budnik. 2012. Wnt signaling in neuromuscular junction development. Cold Spring Harb. Perspect. Biol. 4: a008045.
41. Koles, J. et al. 2012. Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons. J. Biol. Chem. 287: 16820-16834.
42. Zhang, B. et al. 2012. Wnt proteins regulate acetylcholine receptor clustering in muscle cells. Mol. Brain 5: 7.
43. Strochlic, L. et al. 2012. Wnt4 participates in the formation of vertebrate neuromuscular junction. PLoS ONE 7: e29976.
44. Jing, L. et al. 2009. Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/MuSK receptor. Neuron 61: 721-733.
45. Henriquez, J.P. et al. 2008. Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proc. Natl. Acad. Sci. USA 105: 18812-18817.
46. Luo, Z.G. et al. 2002. Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1. Neuron 35: 489-505.
47. Wang, J. et al. 2008. Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. J. Biol. Chem. 283: 21668-21675.
48. Henriquez, J.P. & P.C. Salinas. 2011. Dual roles for Wnt signaling during the formation of the vertebrate neuromuscular junction. Acta Physiol. (Oxf.) 204: 128-136.
49. Stiegler, A.L., S.J. Burden & S.R. Hubbard. 2006. Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK. J. Mol. Biol. 364: 424-433.
50. Zhang, W. et al. 2011. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoblobul-like domain in muscle-specific kinase (MuSK). J. Biol. Chem. 286: 40624-40630.
51. Zong, Y. et al. 2012. Structural basis of agrin-Lrp4-MuSK signaling. Genes Dev. 26: 247-258.
52. Stiegler, A.L., S.J. Burden & S.R. Hubbard. 2009. Crystal structure of the Frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK. J. Mol. Biol. 393: 1-9.
53. Niks, E.H. et al. 2010. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia. Muscle Nerve 42: 283-288.
54. Cole, R.N. et al. 2008. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann. Neurol. 63: 782-789.
55. Richman, D.P. et al. 2011. Acute severe animal model of anti-muscle-specific kinase myasthenia. Arch. Neurol. 69: 453-460.
56. Klooster, R. et al. 2012. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain 135: 1081-1101.
57. Mori, S. et al. 2012. Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. Am. J. Pathol. 180: 798-810.
58. Viegas, S. et al. 2012. Passive and active immunization models of MuSK-ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects. Exp. Neurol. 234: 506-512.
59. Wu, H. et al. 2012. Distinct roles of muscle and motoneuron Lrp4 in neuromuscular junction formation. Neuron 75: 94-107.
60. Yumoto, N., N. Kim & S.J. Burden. 2012. Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. Nature 489: 438-442.
61. Amenta, A.R. et al. 2012. Biglycan is an extracellular MuSK binding protein important for synaptic stability. J. Neurosci. 32: 2324-2334.
62. Sigoillot, S.M. et al. 2010. ColQ controls postsynaptic differentiation at the neuromuscular junction. J. Neurosci. 30: 13-23.
63. Kawakami, Y. et al. 2011. Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology 77: 1819-1826.
64. Simeone, L. 2010. Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction. J. Neurosci. 30: 6620-6634.
65. Ngo, S.T. et al. 2012. Neuregulin-1 potentiates agrin-induced acetylcholine receptor clustering through muscle-specific kinase phosphorylation. J. Cell Biol. 125: 1531-1543.
66. Pilgram, G.S.K. et al. 2010. The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol. Neurobiol. 41: 1-21.
67. Wang, J. et al. 2003. Regulation of acetylcholine receptor clustering by the tumor suppressor APC. Nat. Neurosci. 6: 1017-1018.
68. Takamori, M. et al. 2004. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis. Neurology 62: 1894-1896.
69. Kusner, L.L., Å. Mygland & H.J. Kaminski. 1998. Ryanodine receptor gene expression thymomas. Muscle Nerve 21: 1299-1303.
70. Bhat, M.B. et al. 1997. Functional release channel formed by the carboxyl-terminal protein of ryanodine receptor. Biophys. J. 73: 1329-1336.
71. Skeie, G.O. et al. 2003. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle Nerve 27: 81-89.
72. 2+ signaling. Cold Spring Harb. Perspect. Biol. 2: a003962.
73. 2+ concentrations. Annu. Rev. Pharmacol. Toxicol. 49: 395-426.
74. Lee, E.H. et al. 2006. Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. J. Biol. Chem. 281: 10042-10048.
75. Woo, J.S. et al. 2008. TRPC3-interacting triadic proteins in skeletal muscle. Biochem. J. 411: 399-405.
76. DeHaven, W.I. et al. 2009. TRPC channels function independently of STIM1 and Orai1. J. Physiol. 587: 2275-2298.
77. Harteneck, C. & M. Gollasch. 2011. Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channesls. Curr. Pharm. Biotechnol. 12: 35-41.
78. Roos, J. et al. 2005. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 169: 435-445.
79. 2+ entry. Science 312: 1220-1223.
80. Ong, H.L. et al. 2007. Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in stor-operated and calcium release-activated calcium channel components. J. Biol. Chem. 282: 9105-9116.
81. Cheng, K.T. et al. 2011. Contribution of TRPC1 and Orai1 to Ca(2+) entry activated by store depletion. Adv. Exp. Med. Biol. 704: 435-449.
82. 2+ entry. Proc. Natl. Acad. Sci. USA 106: 3202-3206.
83. Lee, K.P. et al. 2010. An endoplasmic reticulum/plasma membrane junction: STIM1/Orai1/TRPCs. FEBS Lett. 584: 2022-2027.
84. Yuan, J.P. et al. 2007. STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat. Cell Biol. 9: 636-645.
85. Yuan, J.P. et al. 2009. TRPC channels as STIM1-regulated SOCs. Channels (Austin) 3: 221-225.
86. 2+ influx requires the channel function of Orai1 and TRPC1. J. Biol. Chem. 284: 9733-9741.
87. Shen, W.W., M. Frieden & N. Demaurex. 2011. Remodelling of the endoplasmic reticulum during store-operated calcium entry. Biol. Cell 103: 365-380.
88. Berna-Erro, A., P.C. Redondo & J.A. Rosado. 2012. Store-operated Ca(2+) entry. Adv. Exp. Med. Biol. 740: 349-382.
89. Stiber, J. et al. 2008. STIM1 signaling controls store operated calcium entry required for development and contractile function in skeletal muscle. Nat. Cell Biol. 10: 688-697.
90. Vig, M. et al. 2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat. Immunol. 9: 89-96.
91. Dirksen, R.T. 2009. Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle. J. Physiol. 587: 3139-3147.
92. Launikonis, B.S., R.M. Murphy & J.N. Edwards. 2010. Toward the roles of store-oeprated Ca(2+) entry in skeletal muscle. Pflugers Arch. 460: 813-823.
93. Shin, D.M. & S. Maullem. 2008. Skeletal muscle dressed in SOCs. Nat. Cell Biol. 10: 639-641.
94. Lee, E.H. 2010. Ca2+ channels and skeletal muscle diseases. Prog. Biophys. Mol. Biol. 103: 35-43.
95. 2+ homeostasis in skeletal-muscle development and function. Skeletal Muscle 1: 16.
96. Stiber, J.A. & P.B. Rosenberg. 2011. The role of store-operated calcium influx in skeletal muscle signaling. Cell Calcium 49: 341-349.
97. Seth, M. et al. 2012. Dynamic regulation of sarcoplasmic reticulum Ca(2+) stores by stromal interaction molecule 1 and sarcolipin during muscle differentiation. Dev. Dyn. 241: 839-847.
98. 2+ channel isoforms in mouse brain. NeuroReport 9: 507-515.
99. Takamori, M. 2008. Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis. J. Neuroimmunol. 200: 142-144.
100. Iwasa, K., K. Komai & M. Takamori. 1998. Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies. Muscle Nerve 21: 1655-1660.